{"transactions":[{"id":4622980,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-18T23:06:43.000Z","date":"2026-09-16","kind":"grant","planned":false,"acquired":true,"shares":10531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date."}],"balance_after":10531,"derivative":{"exercise_price":39.57,"expiration_date":"2036-09-15","underlying":"Common Shares","underlying_shares":10531},"source":{"system":"sec-edgar","filing":"0001635088-26-000099","document":"wk-form4_1789772800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000163508826000099/wk-form4_1789772800.xml","form_type":"4"}},{"id":4622979,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-18T23:06:43.000Z","date":"2026-09-16","kind":"grant","planned":false,"acquired":true,"shares":5054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date."}],"balance_after":123680,"source":{"system":"sec-edgar","filing":"0001635088-26-000099","document":"wk-form4_1789772800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000163508826000099/wk-form4_1789772800.xml","form_type":"4"}},{"id":4617462,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-14T22:42:32.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2378,"price":40.94,"value":97355.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":118626,"source":{"system":"sec-edgar","filing":"0001635088-26-000092","document":"wk-form4_1789425749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000163508826000092/wk-form4_1789425749.xml","form_type":"4"}},{"id":705182,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-07-22T01:00:16.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":121004,"source":{"system":"sec-edgar","filing":"0001140361-26-029191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036126029191/form4.xml","form_type":"4"}},{"id":803705,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-04-22T01:00:45.000Z","date":"2026-04-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":95,"price":29.83,"value":2833.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":120229,"source":{"system":"sec-edgar","filing":"0001140361-26-015985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036126015985/form4.xml","form_type":"4"}},{"id":803704,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-04-22T01:00:45.000Z","date":"2026-04-17","kind":"grant","planned":false,"acquired":true,"shares":896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":120324,"source":{"system":"sec-edgar","filing":"0001140361-26-015985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036126015985/form4.xml","form_type":"4"}},{"id":933378,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-01-23T02:00:31.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":124,"price":22.98,"value":2849.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":119428,"source":{"system":"sec-edgar","filing":"0001140361-26-002086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036126002086/form4.xml","form_type":"4"}},{"id":933377,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2026-01-23T02:00:31.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":1164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":119552,"source":{"system":"sec-edgar","filing":"0001140361-26-002086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036126002086/form4.xml","form_type":"4"}},{"id":1014667,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-10-23T01:00:59.000Z","date":"2025-10-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":281,"price":17.74,"value":4984.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":118388,"source":{"system":"sec-edgar","filing":"0001140361-25-038995","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125038995/form4.xml","form_type":"4"}},{"id":1014666,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-10-23T01:00:59.000Z","date":"2025-10-20","kind":"grant","planned":false,"acquired":true,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":118669,"source":{"system":"sec-edgar","filing":"0001140361-25-038995","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125038995/form4.xml","form_type":"4"}},{"id":1041540,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-13T01:00:23.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":33726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."}],"balance_after":33726,"derivative":{"exercise_price":13.77,"expiration_date":"2035-09-09","underlying":"Common Shares","underlying_shares":33726},"source":{"system":"sec-edgar","filing":"0001140361-25-034931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125034931/form4.xml","form_type":"4"}},{"id":1041539,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-09-13T01:00:23.000Z","date":"2025-09-10","kind":"other","planned":false,"acquired":false,"shares":2043,"price":13.77,"value":28132.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":117162,"source":{"system":"sec-edgar","filing":"0001140361-25-034931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125034931/form4.xml","form_type":"4"}},{"id":1041538,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-09-13T01:00:23.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":14524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."}],"balance_after":119205,"source":{"system":"sec-edgar","filing":"0001140361-25-034931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125034931/form4.xml","form_type":"4"}},{"id":1084008,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-07-22T01:00:22.000Z","date":"2025-04-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":115,"price":11.65,"value":1339.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":104681,"source":{"system":"sec-edgar","filing":"0001140361-25-026649","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125026649/form4.xml","form_type":"4"}},{"id":1084007,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-07-22T01:00:22.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":2296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":104796,"source":{"system":"sec-edgar","filing":"0001140361-25-026649","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125026649/form4.xml","form_type":"4"}},{"id":1168343,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-04-22T01:00:21.000Z","date":"2025-04-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":64,"price":10.15,"value":649.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":102500,"source":{"system":"sec-edgar","filing":"0001140361-25-014800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125014800/form4.xml","form_type":"4"}},{"id":1168342,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-04-22T01:00:21.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":2635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":102564,"source":{"system":"sec-edgar","filing":"0001140361-25-014800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125014800/form4.xml","form_type":"4"}},{"id":1294430,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-01-28T02:00:26.000Z","date":"2025-01-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":313,"price":11.21,"value":3508.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":99929,"source":{"system":"sec-edgar","filing":"0001140361-25-002100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125002100/form4.xml","form_type":"4"}},{"id":1294429,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-01-28T02:00:26.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":2386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":100242,"source":{"system":"sec-edgar","filing":"0001140361-25-002100","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036125002100/form4.xml","form_type":"4"}},{"id":1382364,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-10-24T01:00:19.000Z","date":"2024-10-21","kind":"grant","planned":false,"acquired":true,"shares":2303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":97856,"source":{"system":"sec-edgar","filing":"0001140361-24-044059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124044059/form4.xml","form_type":"4"}},{"id":1406621,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-09-17T01:00:51.000Z","date":"2024-09-12","kind":"other","planned":false,"acquired":false,"shares":3487,"price":12.12,"value":42262.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the \"net settlement\" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs."}],"balance_after":95553,"source":{"system":"sec-edgar","filing":"0001140361-24-041234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124041234/form4.xml","form_type":"4"}},{"id":1408595,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-13T01:00:20.000Z","date":"2024-09-10","kind":"grant","planned":false,"acquired":true,"shares":27894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."}],"balance_after":27894,"derivative":{"exercise_price":12.19,"expiration_date":"2034-09-09","underlying":"Common Shares","underlying_shares":27894},"source":{"system":"sec-edgar","filing":"0001140361-24-040985","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124040985/form4.xml","form_type":"4"}},{"id":1408594,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-09-13T01:00:20.000Z","date":"2024-09-10","kind":"grant","planned":false,"acquired":true,"shares":16406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."}],"balance_after":99040,"source":{"system":"sec-edgar","filing":"0001140361-24-040985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124040985/form4.xml","form_type":"4"}},{"id":1448671,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-07-26T01:00:56.000Z","date":"2024-07-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":215,"price":11.01,"value":2367.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":82634,"source":{"system":"sec-edgar","filing":"0001140361-24-034281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124034281/form4.xml","form_type":"4"}},{"id":1448670,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-07-26T01:00:56.000Z","date":"2024-07-23","kind":"grant","planned":false,"acquired":true,"shares":2440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":82849,"source":{"system":"sec-edgar","filing":"0001140361-24-034281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124034281/form4.xml","form_type":"4"}},{"id":1534761,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-04-27T01:01:05.000Z","date":"2024-04-24","kind":"tax_withholding","planned":true,"acquired":false,"shares":54,"price":10.9,"value":588.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the \"net settlement\" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares."}],"balance_after":80409,"source":{"system":"sec-edgar","filing":"0001140361-24-022620","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124022620/form4.xml","form_type":"4"}},{"id":1534760,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-04-27T01:01:05.000Z","date":"2024-04-24","kind":"grant","planned":true,"acquired":true,"shares":2121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":80463,"source":{"system":"sec-edgar","filing":"0001140361-24-022620","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124022620/form4.xml","form_type":"4"}},{"id":1673001,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-01-24T02:00:27.000Z","date":"2024-01-19","kind":"grant","planned":false,"acquired":true,"shares":3366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":78342,"source":{"system":"sec-edgar","filing":"0001140361-24-003551","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036124003551/form4.xml","form_type":"4"}},{"id":1758125,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-10-19T01:30:24.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":2269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":74976,"source":{"system":"sec-edgar","filing":"0001140361-23-048776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036123048776/form4.xml","form_type":"4"}},{"id":1776203,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-09-21T01:31:48.000Z","date":"2023-09-18","kind":"other","planned":false,"acquired":false,"shares":8703,"price":11.17,"value":97212.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of Common Shares pursuant to a \"sell-to-cover\" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") previously granted to the reporting person. This sale was effected pursuant to a \"sell to cover\" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4"}],"balance_after":72707,"source":{"system":"sec-edgar","filing":"0001140361-23-044652","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036123044652/form4.xml","form_type":"4"}},{"id":1781034,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T01:31:01.000Z","date":"2023-09-12","kind":"grant","planned":false,"acquired":true,"shares":26595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date."}],"balance_after":26595,"derivative":{"exercise_price":11.22,"expiration_date":"2033-09-11","underlying":"Common Shares","underlying_shares":26595},"source":{"system":"sec-edgar","filing":"0001140361-23-044042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036123044042/form4.xml","form_type":"4"}},{"id":1781033,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-09-15T01:31:01.000Z","date":"2023-09-12","kind":"grant","planned":false,"acquired":true,"shares":17825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date."}],"balance_after":81410,"source":{"system":"sec-edgar","filing":"0001140361-23-044042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036123044042/form4.xml","form_type":"4"}},{"id":1833827,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-07-07T01:30:16.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":1472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":63585,"source":{"system":"sec-edgar","filing":"0001140361-23-033545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036123033545/form4.xml","form_type":"4"}},{"id":1925093,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-04-06T01:30:24.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":1942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":62113,"source":{"system":"sec-edgar","filing":"0001140361-23-016867","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036123016867/form4.xml","form_type":"4"}},{"id":2062662,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-01-06T02:30:45.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":2010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":60171,"source":{"system":"sec-edgar","filing":"0001140361-23-000729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036123000729/form4.xml","form_type":"4"}},{"id":2127120,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2022-11-02T21:58:29.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":2796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":58161,"source":{"system":"sec-edgar","filing":"0001140361-22-039661","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036122039661/form4.xml","form_type":"4"}},{"id":2155697,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-20T01:53:33.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":71850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date."}],"balance_after":71850,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-14","underlying":"Common Shares","underlying_shares":71850},"source":{"system":"sec-edgar","filing":"0001140361-22-033877","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036122033877/form4.xml","form_type":"4"}},{"id":2155696,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true}}],"security":"Common Shares","published_at":"2022-09-20T01:53:33.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":52142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100%  on September 15, 2023, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100%  on September 15, 2023, subject generally to the reporting person's continuous service through such date."}],"balance_after":55365,"source":{"system":"sec-edgar","filing":"0001140361-22-033877","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000114036122033877/form4.xml","form_type":"4"}},{"id":2202813,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":29297,"kind":"person","name":"Oren Ilan","position":1,"cik":"0001643073","reported_name":"Oren Ilan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-07-25T10:05:13.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":3223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date."}],"balance_after":3223,"source":{"system":"sec-edgar","filing":"0000899243-22-026614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643073/000089924322026614/doc4.xml","form_type":"4"}}]}